AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05223517 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: Hwato brand disposable placebo needles (with the handle identical to the needles in the acupuncture group and the body at a size 0.30 × 25 mm) and adhesive pads will be used. Acupoints of Ciliao, Huiyang, Shenshu, Guanyuan, Shuidao, Sanyinjiao, Zusanli, Taixi, Hegu, and Taichong will be used for every participants. Those with sleep or mood disorders will also use acupoints of Shangyintang, Shenmen and Neiguan. Those with tenderness points on the abdominal wall will also use Ashi points no more than five.~The needles will be inserted into adhesive pads without skin penetration. Needles will be lifted, thrusted and twirled gently for 3 times to mimic real acupuncture. No manipulation will be conducted during 20-minute maintenance in prone and supine position respectively.~Participants receive sham acupuncture treatment three times a week in the first four weeks and twice a week in the last four weeks.
Study NCT04837976 — intervention group
Intervention type: OTHER
Intervention: Semi-structured interviews and a consensus workshops using nominal group techniques.
Description: Stage 1 of the study includes individual remote semi-structured interviews (one per participant). Stage 2 involves taking part in a consensus workshop with around 7 other Parkinson's experts, consisting of patients, supportive individuals and healthcare professionals.
Study NCT05445440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Specified dose on specified days
Study NCT05445440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin
Description: Specified dose on specified days
Study NCT05445440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986371
Description: Specified dose on specified days
Study NCT05445440 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sulfasalazine
Description: Specified dose on specified days
Study NCT06033118 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine ,oxaliplatin,anlotinib,Sintilimab
Description: Gemox chemotherapy（gemcitabine 1g/m2 ivgtt d1,d8 +oxaliplatin 85g/m2 ivgtt d1，q3w，anlotinib (8mg po d1-14 q3w )and Sintilimab (200mg ivgtt d1 q3w)
Study NCT06340100 — intervention group
Intervention type: OTHER
Intervention: find association between vestibular impairment , cognitive fiunction with concussin
Description: SCOAT 6 is a standardized tool used for evaluating athletes suspected of having a concussion. It includes a variety of components such as symptom evaluation, cognitive assessment, balance evaluation, and a neck examination. it helps in assessing the severity of the injury, tracking recovery, and making return-to-play decisions. Dr. Robert Cantu, a prominent figure in sports concussion research, has proposed guidelines for the management of concussions. These guidelines typically involve recommendations for the evaluation, treatment, and return-to-play decisions for athletes who have sustained concussions
Study NCT05772923 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Contact x-ray brachytherapy
Description: With contact x-ray brachytherapy an intraluminal radiation boost up to 90 Gy is applied to the primary rectal tumour, with minimal collateral damage to the surrounding normal tissues due to minimal penetration of the 50 kVolt therapy.
Study NCT05772923 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Local excision
Description: Local excision will basically be performed by the TAMIS-procedure (transanal minimally invasive surgery).
Study NCT04768335 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: cognitive experiments' session
Description: The aim of this unique session of cognitive experiments is to study the links between source memory deficits and externalization abilities in healthy control subjects. Results of this Arm 2 will be compared to those of Arm 1.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dinner
Description: Study subjects will consume a standardized ready-to-eat meal as dinner.
Study NCT06522711 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality headset
Description: A brief overview of all three virtual reality scenarios will be shown in a consolidated video prior to letting the participant select the preferred scenario. The participant's choice of scenario will then be documented. Once paravertebral blocks are completed and the participants are in supine position and the surgeon is ready to disinfect, the VR headset will be applied on the face of the participants in the intervention group and the chosen scenario will be started. If at any point the patient expresses a desire to stop using VR during the surgery, we will first offer them an alternate scenario. If they reiterate their willingness to stop, with or without having experienced the new scenario, the headset will be removed for the remainder of the surgery.
Study NCT06522711 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Standard of care in anesthesia with patient-controlled sedation.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dinner
Description: Study subjects will consume a standardized ready-to-eat meal as dinner.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fasting
Description: Subjects will be asked to fast overnight for approximately 15 hours.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fasting
Description: Subjects will be asked to fast overnight for approximately 15 hours.
Study NCT04094948 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clenbuterol
Description: 20 mcg spiropent tablets will be overencapsulated (two 20 mcg tablets per capsule)
Study NCT04996329 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: early health warning intervention
Description: early health warning intervention is to tell the subjects that smoking leads to the rapid decline of their lung function, and they are at the high risk of developing COPD.
Study NCT04996329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: early health warning intervention
Description: early health warning intervention is to tell the subjects that smoking leads to the rapid decline of their lung function, and they are at the high risk of developing COPD.
Study NCT05811325 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesiotaping without craniosacral therapy
Description: The first treatment group will receive kinesio taping for 6 weeks atleast 4 times per week
Study NCT05811325 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: kinesiotaping with craniosacral therapy
Description: The second treatment group will receive kinesio taping with craniosacral therapy for 6 weeks atleast 4 times per week with each session lasting for 60 minutes
Study NCT06050980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK40118
Description: Oral administration, QD
Study NCT04380155 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Moderate intensity cycling trials of different duration (30, 60 and 120 min)
Study NCT05561452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single PRP Injection
Description: In single-PRP injection group, 10 ml of venous blood taken from the patients will be put into the T-LAB® PRP kit (T-Biotechnology Laboratory, İstanbul, Turkey) and will then be centrifuged at 3850 rpm for 8 minutes. Approximately 4 ml of the PRP obtained will be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.
Study NCT05561452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multiple PRP Injections
Description: In multiple-PRP injection group, two PRP injections will be performed with an interval of 3 weeks. 10 ml of venous blood taken from the patients will be put into the T-LAB® PRP kit (T-Biotechnology Laboratory, İstanbul, Turkey) and will then be centrifuged at 3850 rpm for 8 minutes. Approximately 4 ml of the PRP obtained is planned to be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.
Study NCT05561452 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo Injection
Description: In placebo-injection group,10 ml of venous blood will be taken and after the same waiting time 4 ml of 0.9% saline will be injected into the subacromial space using the lateral subacromial injection method under ultrasound guidance. All injections will be performed in the sagittal axis with the long axis in-plane technique, using the ultrasound device (Esaote My Lab 70 XVision 6-18 Mhz linear probe).~A physical therapy program including Codman pendulum exercises, shoulder range of motion, stretching and strengthening exercises will be given and be performed at least for 20 minutes daily.
Study NCT06267131 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Brain Pulse Oximeter
Description: Sensor is placed on the right and/or left forehead and maintained with an elasticized headband. The duration of monitoring will last for approximately 60 minutes per monitoring session to obtain sufficient data. Serial monitoring will occur on three consecutive days.
Study NCT06555653 — intervention group
Intervention type: OTHER
Intervention: Video based multimedia information
Description: The intervention group was shown a 5 minute informational video before amniocentesis including definition of amniocentesis, its indications, the setup of amniocentesis room, the purpose and steps of the procedure, potential complications and how to manage them
Study NCT05789485 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: structured treadmill walking
Description: Three doses of AT (i.e., 90, 150, or 300 mins/week) will be tested. All doses will consist of individualized walking delivered up to 7 times per week delivered throughout treatment.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fast Bar
Description: Subjects will be asked to consume a Fast Bar.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bar with Coffee
Description: Subjects will be asked to consume a Fast Bar with coffee.
Study NCT04790552 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bar with Tea
Description: Subjects will be asked to consume a Fast Bar with tea.
Study NCT01954472 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced portfolio plus structured exercise
Description: Foods on the dietary portfolio plan will contribute 9g/1000 kcal viscous fibre as β-glucan (oats, barley, oat bran breads and soups) and psyllium (cereal), 1g plant sterol/1000 kcal diet (in sterol margarine), 22.5g soy protein/1000 kcal (soy burgers, dogs, links, other soy meat analogues, soy milks, yogurts and cheese), and additional sources of plant protein from pulses (eg. Lentils, chickpeas, beans, etc) and 22.5g almonds or equivalent of other nuts/1000 kcal and increased MUFA (as olive and canola oils, avocados, nuts, margarine and salad dressings). The glycemic index will be reduced from 83 to 70 GI units (bread scale).~Exercise: The physical activity/exercise program is based on the program used at the Quebec Heart and Lung Institute.
Study NCT01954472 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: High fiber diet plus routine exercise
Description: Dietary advice will be given to encourage intake of whole grain foods (brown rice, whole wheat breads, muffins and breakfast cereals); to reduce meat consumption, choose low fat dairy products and a control margarine.~Exercise: A pamphlet (Canada's Physical Activity Guide, Health Canada) encouraging increased physical activity will be provided.
Study NCT05318105 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Aquadex Smartflow® System
Description: ultrafiltration
Study NCT05318105 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: IV Loop Diuretics
Description: diuretics
Study NCT05562284 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: intra-arterial thrombolysis
Description: IAT introduces rt-PA directly into the ophthalmic circulation by super-selective microcatheterization.
Study NCT05562284 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: conservative treatments
Description: conservative treatments
Study NCT05562284 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conservative treatments
Description: conservative treatments
Study NCT04822272 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI thermometry
Description: MRI sequence of 5 to 10 minutes to measure the variation of temprerature in the prostate
Study NCT05887947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 1.8% 5% 1.8%
Description: At lab visit 1 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 1.8% electronic cigarette pod nicotine concentration for 6 weeks of home use.
Study NCT05887947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 1.8% 5% 5%
Description: At lab visit 1 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 5% electronic cigarette pod nicotine concentration for 6 weeks of home use.
Study NCT05887947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 5% 1.8% 1.8%
Description: At lab visit 1 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 1.8% electronic cigarette pod nicotine concentration for 6 weeks of home use.
Study NCT05342818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Neostigmine
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs
Study NCT05342818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron 8mg
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs
Study NCT05342818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metoclopramide Injection
Description: will be given by infusion in 20 minutes once daily by a nurse blinded to the study drugs
Study NCT05342818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Enteral feeding nutrition
Description: The type and rate of enteral feeding nutrition will be the same for all patients (180ml/3h). All patients have a 30-degree head-up position
Study NCT05342818 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Sequential Organ Failure Assessment (SOFA) score
Description: SOFA score will be performed on all patients before the beginning of the study
Study NCT04094948 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: dextrose-filled capsules
Study NCT05457517 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL-13027，Sintilimab
Description: YL-13027 combined with Sintilimab will be used as a cycle for 21 days. YLl-13027 is administered orally twice a day. Starting dose of YL-13027 is 240mg/d，with escalation to 360mg/d in phase Ib, and RP2D was administered orally twice a day in phase II.~Sindilizumab is administered intravenously 200mg every three weeks
Study NCT05787002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD0780
Description: AZD0780 will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.
Study NCT05787002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Rosuvastatin will be administered orally as a single dose after an overnight fast of at least 10 hours with approximately 240 mL of water.
Study NCT05887947 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Cigarette Nicotine Concentration Order 5% 1.8% 5%
Description: At lab visit 1 participants receive 5% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 48 hours, at lab visit 2 participants receive 1.8% electronic cigarette pod nicotine concentration during the 10-puff standardized puff bout and 60-minute ad libitum session.~After a washout period of at least 7 days, during phase two, participants received 5% electronic cigarette pod nicotine concentration for 6 weeks of home use.
Study NCT05506358 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: High performance liquid chromatography
Description: High performance liquid chromatography (HPLC) using the D10 System by Bio-Rad Laboratories will be used as the gold standard test.
Study NCT05506358 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Automated sickling test
Description: The standard sickling test using 2% sodium metabisulphite will be augmented using an automated microscope (such as Octopi) and machine learning, and will be used as one of the low-cost tests.
Study NCT05506358 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: HbS solubility test
Description: Standard HbS solubility test currently used in Nepal (e.g. Sicklevue) will be used as one of the low-cost tests
Study NCT05506358 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: HemoTypeSC
Description: A point-of-care lateral flow assay, HemoTypeSC (https://www.hemotype.com/), will be used as one of the low-cost tests
Study NCT05506358 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Sickle SCAN
Description: A point-of-care lateral flow assay, Sickle SCAN (https://www.biomedomics.com/products/hematology/sicklescan/), will be used as one of the low-cost tests
Study NCT05506358 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Gazelle Hb Variant Test
Description: A portable electrophoresis machine, Gazelle diagnostic device (https://hemexhealth.com/), will be used as one of the low-cost tests
Study NCT06256965 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Detection of peri-operative atrial fibrillation
Description: atrial tissue and plasma from patients with atrial fibrillation detection were analyzed for determine lipid and protein oxidation, and detect markers of myocardial injury.
Study NCT05713461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: exercise training program
Description: Adapted Interval Training Intervention, three days a week, 10 weeks.~Warm-up 10': Joint mobility and cardiovascular activation~Main part:~Resistance training circuit for strengthening the main muscle groups.~Cool down Flexibility and CORE
Study NCT02917226 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical decision support and monitoring system
Study NCT05713461 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Feeding training
Description: Two workshops on healthy eating habits (Week 1 and week 5). Food Frequency Questionnaires (weekly). Feedback weekly. Mediterranean Diet Adherence Screener (MEDAS). The dietary intervention will be based on the nutritional recommendations based on the Mediterranean diet, according to the evidence from the PREDIMED trial.
Study NCT06122441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex lifestyle intervention
Description: The complex lifestyle intervention comprise high-intensity aerobic and strength exercise, behavioral counselling based on Acceptance and Commitment Theory (ACT), and dietary counselling based on Norwegian nutritional guidelines. The different intervention elements are introduced step-wise to reduce initial overload. Participants are progressively transitioned over to the Tromsø municipality and local NGO's, who delivers activities harmonized with the intervention elements. Participants are at this stage also supported by an eTool which digitally reinforces the intervention through web-based information and videos.
Study NCT06122441 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity monitoring and recommendations
Description: Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.
Study NCT06122441 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical activity monitoring and recommendations
Description: Wrist-worn activity trackers that are worn throughout the trial, which monitors steps, activity intensity and energy expenditure. Access to Norwegian physical activity guidelines via the Directorate of Health.